About Us

Milltrust International Group is a specialist investment organisation, co-headquartered in the asset management hubs of London and Singapore, with regional offices in some of the most dynamic markets in the world.

Public
Investments

Public Investments description: With a unique multi-geography multi-affiliate structure, Milltrust provides a range of unique and sustainable investment solutions in the public markets.

Venture
Investments

We are passionate about the ideas, technologies and the business models that are reshaping the world, actively investing into solutions to the world's greatest challenges.

News & Media

News

All the latest news, articles, commentaries, press releases, and media coverage of Milltrust International Group and its affiliates.

Contact Us

Milltrust International Group is co-headquartered in the asset management hubs of London and Singapore, with regional offices, affiliates and strategic partnerships around the world.

Stay in Touch

To keep in touch, please sign up to the Milltrust Ventures Newsletter for our latest news and insights.

Subscribe Here

Home

\
News
\
News & Media
\
Why Gates and Zuck think the next drug blockbusters will come from your gut

Why Gates and Zuck think the next drug blockbusters will come from your gut

April 9, 2020

BY Alexander Kalis
MANAGING PARTNER

On the bravest frontier in human health, scientists are using bacteria from the digestive system to create novel medicines for a huge range of ailments including Parkinson’s, cancer and autism. The results could transform lives and deliver massive returns for early investors

Milltrust’s VC partner Cerracap was a day 1 investor into Viome. We are proud to have helped pioneered this fascinating technology which uses AI to analyse millions of data points derived from the contents of our gut.